Research suggests that Gymnema sylvestre may play a role in weight management, though the current evidence base is limited in scope and quality. Available studies include an animal study in rats with metabolic syndrome, which found that a Gymnema sylvestre extract reduced body weight and improved blood lipid profiles, with effects that persisted even after supplementation was discontinued, and a cross-sectional survey study in humans that examined Gymnema sylvestre among a broader group of anti-obesity products, finding a general association with milder COVID-19 symptoms and some interaction with weight management outcomes. Both studies point in a broadly supportive direction, but neither constitutes the kind of rigorous, controlled human clinical trial that would allow strong conclusions to be drawn. The animal study cannot be directly extrapolated to humans, and the survey study relied on self-reported data from a specific population, meaning the evidence at this stage is preliminary and further well-designed human trials would be needed to establish any reliable effect on weight management.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Cross-relationship between COVID-19 infection and anti-obesity products effic... | Other | 2024 | Supports | 100 |
| Decreased bodyweight without rebound and regulated lipoprotein metabolism by ... | Other | 2007 | Supports | 95 |